[ad_1]

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Author affiliation: Shandong First Medical University, Jinan, China (M. Shen, B. Fu, C. Yu, C. Cui, K. Wang, Z. Wang); Agro-biological Gene Research Center of Guangdong Academy of Agricultural Sciences, Guangzhou (J. Yu); Shandong Provincial Center for Animal Disease Control, Jinan (S. Chen, C. Liu)

Since its initial isolation from a pig with respiratory symptoms in 2011, influenza D virus (IDV) has been documented in cattle, small ruminants (e.g., sheep), dogs, camels, and wild ungulates (13). Similar to other influenza viruses, IDV carries genetic traits that might aid in host range expansion and virulence enhancement; genetic adaptations frequently occur during cross-species transmission events (4).

Donkeys are economically important livestock species in China. Because of the widespread distribution and high seroprevalence of IDV in cattle in China (5), along with the frequent interactions among domestic animals in rural areas of the country, investigating donkey exposure to IDV is essential to assess the virus’s risk to animal health.

This study used a cross-sectional design. A total of 315 serum samples were randomly collected from black donkeys (Equus asinus, a local breed) across 9 commercial farms in northern China. Sampling was conducted regardless of age or sex. All serum specimens were preserved at –80°C and tested within 6 months of collection. C.L. provided all samples. We obtained receptor-destroying enzyme (RDE) from Denka Seiken Co. Ltd (https://denka-seiken.com), and we purchased chicken red blood cells from Wuhan Keyi Biotechnology Co. Ltd (https://m.labbase.net/CompanyIndex-16219.html). J.Y. provided MDCK cells, which we maintained in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum. J.Y. provided all viral strains used in this study, which included IDV (D/bovine/CHN/JY3002/2022), influenza A virus (A/People’s Republic of China/SWL1304/2023), and influenza B virus (B/Guangdong/266/2021. For hemagglutination inhibition (HI) assays, we treated serum samples with RDE (1:3 ratio, 37°C for 18–20 hours, 56°C for 30–60 minutes) (6).

All animal procedures in this study were reviewed and approved by the Animal Ethics Committee of Shandong First Medical University (approval no. W202502250029). Sampling was conducted under veterinary supervision in accordance with national guidelines for the care and use of animals.

We mixed viral antigen (4HAU) with serially diluted serum samples (1:10 starting in phosphate-buffered saline in V-bottom plates, incubated them at 37°C for 30 minutes, and assessed them with 0.5% chicken red blood cells at room temperature for 15 minutes. HI titers were the highest dilution inhibiting hemagglutination (we defined a titer >10 as positive). The HI >10 cutoff was validated in prior IDV studies to balance sensitivity and specificity; using a higher cutoff generally lowers apparent seroprevalence, whereas a lower cutoff increases sensitivity and can raise estimated prevalence (7).

Virus neutralization (VN) assays used IDV (100 tissue culture infectious dose 50). We mixed RDE-treated serum specimens (2-fold dilutions in Dulbecco’s modified Eagle medium from 1:10) with virus at 37°C for 1 hour), inoculated them onto MDCK cells, and observed them for cytopathic effect at 37° C in 5% CO2 for 48–72 hours. Neutralizing titers were the reciprocal of the highest dilution showing complete cytopathic effect inhibition (we defined a titer >10 as positive) (8).

Among 315 donkey serum samples collected from 9 distinct farms in northern China, 6 (1.9%, 95% CI 0.7%–4.1%; p = 0.006) were HI-positive for IDV; 3 of those 6 were positive samples exhibiting HI titers of 40. Furthermore, 5 HI-positive samples were confirmed by virus neutralization (VN) assays, demonstrating VN titers ranging from 10 to 40. We detected no influenza A virus or influenza B virus antibodies (Table). Geographically, positive samples were clustered in farms in 2 different cities: 1 farm showed a seroprevalence of 3.07% (2 of 65 samples), and the other exhibited a higher rate of 4.08% (4 of 98 samples).

Although the 1.9% infection rate was substantially lower than that reported in cattle (77.5%) (9), our findings indicate that donkeys might be a novel host species. This development expands the known host range of IDV and underscores the need to reassess its cross-species transmission potential. This study is limited by its small sample size, restricted geographic coverage, and the lack of detailed farm management data, which prevented assessment of potential risk factors. To address those gaps, future work should include broader serologic surveys, genomic surveillance, and targeted studies in mixed farming systems. A previous study reported IDV antibody prevalence in horses in the United States (10). Together with our finding in donkeys, that finding suggests that multiple equid species might serve as IDV hosts, broadening the ecologic and epidemiologic understanding of IDV. These results highlight the need for continued One Health surveillance and reassessment of cross-species transmission risks.

Mr. Shen is a master’s student at the College of Laboratory Animals at Shandong First Medical University. His main research interest is the study of influenza virus pathogenicity factors.

Top

This work was supported by National Natural Science Funds (grant nos. 32102750 and 32300122), Shandong Province Pig Industry Technology System (grant no. SDAIT-08-17), the Major Scientific and Technological Innovation Project (grant no. 2023CXGC010705), the special funds (grant nos. R2021YJ-QG008 and R2023PY-JX025) for Talent Introduction Program from Guangdong Academy of Agricultural Sciences, the Innovation Project of Shandong Academy of Medical Sciences and Technology Bureau “20 Colleges and Universities” (grant no. 2021GXRC011), and the Provincial Natural Science Foundation of China (grant no. ZR2022QC137).

Author contributions: conceived and designed the experiments (M.S., Z.W., K.Z., J.Y., and B.F.); performed the experiments (M.S., C.Q., S.M., and C.L.); analyzed the data (M.S., S.M., B.F., and C.L.); contributed serum samples, strains, or reagents (C.L., J.Y., and Z.W.); wrote the paper (M.S. and Z.W.).

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *